Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 34
Filtrar
1.
Complement Ther Clin Pract ; 24: 162-6, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27502817

RESUMEN

CONTEXT: Faecal incontinence is defined as the involuntary loss of intestinal contents (whether faeces or gas). Although it is not frequently reported, it does cause physical and psychological distress. Traditional Chinese medicine believes that the healthy human body is originally in a state of balanced energy (Qi) between Yin and Yang, and all disorders that occur in the body are explained by disruptions in this energy balance. Acupuncture is a valuable therapy and is used as a therapeutic approach for the treatment of pelvic floor dysfunction. Data regarding faecal incontinence and acupuncture is scarce. This research describes the efficacy of using acupuncture in patients with faecal incontinence. PATIENTS AND METHODS: Eighteen adults (2 men and 16 women) underwent acupuncture therapy with traditional acupuncture needles for 10 weeks. Before and after treatment, all patients completed a Fecal Incontinence Quality of Life (FIQL) survey and the incontinence intensity was assessed using a visual analogue scale. RESULTS: After 10 sessions of acupuncture, all patients reported an improvement, and the vast majority of patients showed statistically significant improvements in both tests. CONCLUSION: Therefore, evidence now shows that acupuncture can improve the quality of life of patients undergoing faecal incontinence treatment.


Asunto(s)
Terapia por Acupuntura , Incontinencia Fecal/terapia , Calidad de Vida , Adulto , Anciano , Femenino , Encuestas Epidemiológicas , Humanos , Masculino , Persona de Mediana Edad , Diafragma Pélvico/fisiopatología , Qi , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
2.
Arq. bras. med. vet. zootec ; 64(5): 1145-1150, out. 2012. ilus, tab
Artículo en Inglés | LILACS | ID: lil-655884

RESUMEN

Tumor invasion of the vessels displays both therapeutic and prognostic implications and represents a challenge for head and neck surgeons. Although previous research has shown that ultrasound can detect such invasions, accurate sonographic parameters to do so have not yet been established. We sought to determine sonographic criteria which are able to characterize these invasions. A high-resolution transducer was used to perform ultrasound examinations of 15 patients selected from a group with inconclusive radiography and computed tomography diagnosis. We found that encasement of the vessel, tumor immobility or fixation in the vessel wall, and narrowing and/or deformity of the lumen were the best criteria. Indeed, when loss of hyperechoic interface of the vessel wall was used as a single criterion it generated false positive results. This study shows that a combination of parameters can be used to provide the best sensitivity and specificity values to produce conclusive diagnosis of vessel invasion by tumors in the cervical region.


Determinaram-se critérios ultrassonográficos capazes de caracterizar a invasão vascular por tumores em cães. Utilizaram-se transdutores de alta resolução para os exames ultrassonográficos realizados em 15 pacientes, selecionados de um grupo submetido previamente à radiografia e tomografia computadorizada, com resultados inconclusivos. Os melhores critérios encontrados foram: encarceramento do vaso, imobilidade do tumor ou aderência na parede vascular e estreitamento ou deformidade luminal. A perda de definição da interface hiperecoica da parede vascular quando foi usada como critério isolado produziu resultados falso positivos. O estudo demonstrou que uma combinação de parâmetros pode ser usada para aumentar a sensibilidade e especificidade diagnóstica, produzindo diagnósticos mais conclusivos e precisos pra definir a invasão vascular por tumores na região cervical ventral.


Asunto(s)
Animales , Perros , Neoplasias Vasculares/diagnóstico , Neoplasias Vasculares/veterinaria , Núcleos Talámicos Ventrales , Perros/metabolismo , Radiografía/veterinaria , Tomografía Computarizada por Rayos X/veterinaria , Ultrasonografía/veterinaria
3.
Rev Med Suisse ; 6(233): 192-4, 196-7, 2010 Jan 27.
Artículo en Francés | MEDLINE | ID: mdl-20214191

RESUMEN

Gastrointestinal bleeding is among the major clinical challenges for the gastroenterologists and the initial approach is very complex. For a big part of bleeding lesions, it is important to perform an endoscopic hemostatis after the introduction of an intravenous treatment (that has to be started as soon as there is a clinical suspicion of an upper gastrointestinal bleeding). The significant progresses made during the last years have allowed firstly to see the entire small bowel mucosa (video capsule) and secondly new treatments have successfully replaced surgical interventions.


Asunto(s)
Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/terapia , Enfermedad Aguda , Endoscopía Gastrointestinal , Hemorragia Gastrointestinal/diagnóstico , Humanos , Melena/diagnóstico , Melena/etiología
4.
Rev Med Suisse ; 5(187): 167-70, 172-5, 2009 Jan 21.
Artículo en Francés | MEDLINE | ID: mdl-19271427

RESUMEN

The treatment of reflux disease did not change in the review period. PPI therapy remains the first line treatment and surgery the second line approach. Endoscopic anti-reflux procedures should be only performed in controlled studies. Beside the classic triple therapy, sequential treatment of Helicobacter pylori infection can today be considered as a first line therapy. PPI are effective in the prevention of gastroduodenal lesions and in the treatment of dyspeptic symptoms induced by NSAIDs treatment. Only patients younger then 65 years and without any risk factors do not need a preventive PPI prescription during classic NSAIDS treatment.


Asunto(s)
Reflujo Gastroesofágico/terapia , Antiulcerosos/uso terapéutico , Procedimientos Quirúrgicos del Sistema Digestivo , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Inhibidores de la Bomba de Protones/uso terapéutico
5.
Rev Med Suisse ; 2(49): 182-6, 188-90, 2006 Jan 18.
Artículo en Francés | MEDLINE | ID: mdl-16493961

RESUMEN

A new generation of PPI are presently in clinical trials. They are characterized by a quicker and longer effectiveness, very useful for reflux disease treatment. We have to note that the enthusiasm towards the endoscopy treatment for reflux disease is clearly deceasing and two types of procedures have even been recalled from the market. In Helicobacter pylori eradication treatments the tendency tends towards high doses of antibiotics for the second option treatments. The indication for a COX-2 treatment is largely reduced due to the cardiac side effects of certain COX-2. For the patients with high risk of gastro-duodenal toxicity through AINS, the alternative remains the classical non-specific AINS treatment associated with a PPI.


Asunto(s)
Inhibidores Enzimáticos/uso terapéutico , Enfermedades del Esófago/terapia , Inhibidores de la Bomba de Protones , Gastropatías/terapia , Úlcera Gástrica/tratamiento farmacológico , Ensayos Clínicos como Asunto , Inhibidores de la Ciclooxigenasa 2/efectos adversos , Inhibidores de la Ciclooxigenasa 2/uso terapéutico , Enfermedades del Esófago/fisiopatología , Infecciones por Helicobacter/tratamiento farmacológico , Humanos , Factores de Riesgo , Gastropatías/fisiopatología
6.
Rev Med Suisse ; 1(3): 200-2, 205-8, 2005 Jan 19.
Artículo en Francés | MEDLINE | ID: mdl-15770814

RESUMEN

The therapeutical acquisitions of the year 2004 are: 1. The sequential treatment of the Helicobacter pylori infection reaches an eradication rate of 95%. 2. The use of COX-2 inhibitors reduced significantly the gastrointestinal side effects of anti-inflammatory treatments. Since cardiac averse effects of certain COX-2 inhibitors had been reported, the treatments with COX-2 inhibitors came widely into question. In the case of patients with risk of NSAID induced gastrointestinal toxicity, the alternative is to return to a treatment with non specific NSAID associated to an prophylactic PPI treatment.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Inhibidores de la Ciclooxigenasa/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Gastropatías/tratamiento farmacológico , Antiinflamatorios no Esteroideos/uso terapéutico , Esófago de Barrett/cirugía , Reflujo Gastroesofágico/cirugía , Helicobacter pylori/patogenicidad , Humanos , Úlcera Gástrica/etiología , Úlcera Gástrica/microbiología , Úlcera Gástrica/prevención & control
7.
Digestion ; 65(1): 2-10, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-11961336

RESUMEN

BACKGROUND: Conventional techniques for measuring gastric acidity have demonstrated the decrease in gastric acidity produced by proton pump inhibitors (PPI); however, such techniques do not detect transient or localized pH changes which may modify the intragastric environment without affecting the therapeutic efficacy of PPIs. AIM: To investigate local and temporal variations in intragastric pH and to test the hypothesis that omeprazole produces prolonged, generalized gastric anacidity (pH >6). METHODS: A single-blind study was conducted with triple-point 24-hour gastric pH-metry on days 7, 14 and 21 in 14 healthy, Helicobacter pylori-negative volunteers (7 M; 20-46 years) who received placebo for 7 days, followed by omeprazole 20 mg daily for 14 days. RESULTS: Omeprazole increased the median 24-hour pH significantly in the distal corpus (placebo: 1.3 (95% CI 1.1 to 1.6); omeprazole week 1: 4.0 (2.6-5.0); omeprazole week 2: 4.0 (2.8-4.6)) and at all other gastric recording sites (p < 0.01). At both corpus sites, nocturnal pH was lower and mealtime pH was higher than the non-meal daytime pH during placebo and both omeprazole administration periods; in the antrum, however, the major difference noted was that meal-time pH was higher than non-meal daytime pH. Antral pH was lower during meals and higher at night than proximal corpus pH. During placebo, gastric pH >6.0 was observed at 1 site only for 1.7% (median; 95% CI 0.4-3.3%), at 2 sites simultaneously for 0.24% (0.0-1.0%) and at 3 sites for 0.0% (0.0-0.28%), respectively, of the recording periods; during the second week of omeprazole, the equivalent results were 7.7% (1.4-14.0%), 4.9% (0.21-15.7%) and 4.7% (0.0-9.9%), respectively. CONCLUSIONS: Omeprazole, 20 mg daily, does not produce gastric anacidity despite significant increases in median 24-hour pH values. The time-, meal- and site-related variations in gastric pH observed under normal physiological conditions are seen to persist, with prolonged periods of low pH throughout the stomach and preservation of the normal, meal-related rise and nocturnal fall in gastric pH during omeprazole administration.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Omeprazol/farmacología , Ritmo Circadiano , Electrodos , Inhibidores Enzimáticos/administración & dosificación , Femenino , Ácido Gástrico/metabolismo , Determinación de la Acidez Gástrica , Humanos , Concentración de Iones de Hidrógeno , Masculino , Omeprazol/administración & dosificación , Método Simple Ciego
8.
J Org Chem ; 66(25): 8336-43, 2001 Dec 14.
Artículo en Inglés | MEDLINE | ID: mdl-11735511

RESUMEN

The stereoselective synthesis of both enantiomers of trifluoro frontalin (-)-(1S,5R)- and (+)-(1R,5S)-8, as well as of diastereomeric monofluoro frontalines (-)-(1R,2R,5R)-18 and (-)-(1R,2S,5R)-20, analogues of the bioactive component of the aggregation pheromone of the Scolytidae insect family, has been accomplished starting from (-)-(1R)- and (+)-(1S)-menthyl (S)-toluene-4-sulfinate as a source of chirality and methyl trifluoroacetate or fluoroacetate, respectively, as sources of fluorine. The C-1 stereocenters were installed via stereoselective epoxidation of beta-sulfinyl ketones 2 and 13 with diazomethane. The bicyclic core was obtained by totally stereocontrolled and chemoselective tandem Wacker oxidation/intramolecular ketalization of the intermediate unsatured sulfinyl diols 5, 15, and 19. Axially fluorinated (-)-20 elicited a strong electroantennographic response in laboratory tests on females of Dendroctonus micans, whereas equatorially fluorinated (-)-18 and the trifluoroanalogue (-)-8 showed modest responses. Field trials using (-)-20 were not indicative owing to the locally scarce population of D. micans, but it showed some attractiveness for other Coleoptera families.


Asunto(s)
Compuestos Bicíclicos Heterocíclicos con Puentes/síntesis química , Feromonas/antagonistas & inhibidores , Animales , Conducta Animal/efectos de los fármacos , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Escarabajos , Electrofisiología , Femenino , Flúor , Indicadores y Reactivos , Control de Insectos , Feromonas/biosíntesis , Órganos de los Sentidos , Estereoisomerismo
10.
Ther Umsch ; 58(3): 146-50, 2001 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-11305152

RESUMEN

Reflux esophagitis is a frequent and chronic disease. Impairment of the quality of life by the reflux symptoms and the risk of complications are the most important indications for a long-term treatment. The base of the treatment of reflux esophagitis is the inhibition of the gastric acid secretion with proton pump inhibitors (PPI) or by H2-receptor antagonist. In general, PPI's are more efficient in the treatment of refluxesophagitis as compared to H2-receptor antagonists blockers regarding the relieve of symptoms and the healing of erosive esophageal lesions. The use of an antacids and procinetics in the long-term treatment is not indicated. The treatment strategy depends on the severity of the symptoms and the esophageal lesions. Patient with mild esophagitis can be treated either with H2-receptor antagonists or with PPI's on demand or continuous. In the case of severe esophagitis, a long-term treatment with PPI's is indicated to avoid complications. Recurrence of esophagitis during a long-term therapy should be treated by PPI's. After healing the long-term treatment should be adapted either by increasing the given dose of the medicament or by a switch to more effective medicaments in acid suppression.


Asunto(s)
Antiulcerosos/uso terapéutico , Esofagitis Péptica/tratamiento farmacológico , Infecciones por Helicobacter/complicaciones , Omeprazol/uso terapéutico , Factores de Edad , Antiulcerosos/efectos adversos , Dieta , Quimioterapia Combinada , Esofagitis Péptica/complicaciones , Esofagitis Péptica/dietoterapia , Humanos , Omeprazol/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Tiempo , Resultado del Tratamiento
11.
Mycoses ; 44(11-12): 480-6, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11820261

RESUMEN

To characterize strains of Microsporum canis that infect dogs and cats in São Paulo city, 30 isolates of this dermatophyte were tested for their ability to assimilate carbon and nitrogen sources, for proteinase and phospholipase secretion, for susceptibility to yeast killer toxins, and for susceptibility to the antifungals fluconazole, ketoconazole, itraconazole, 5-fluorocytosine and amphotericin B, in E test. All samples assimilated the nitrogen sources asparagine, ammonium sulphate, urea and sodium nitrate, as well as the carbon sources inulin, mannitol, trehalose, meso-erythritol, maltose, mannose, sorbitol, cellobiose, fructose and dextrin. Not all the samples assimilated adonitol, galactose, arabinose, rhamnose, raffinose, melibiose, ribose and sucrose, and none of them was capable of growing with dulcitol, lactose, or xylose as the only carbon source. Proteinase and phospholipase secretion was observed for most isolates. In the test of yeast killer toxin, 10 types could be identified, with four types exclusively observed in isolates from dogs and two types exclusively observed in isolates from cats. In the E test, all isolates were found to be resistant to the fluconazole and 5-fluorocytosine, while they were variably sensitive to amphotericin B, ketoconazole and itraconazole. When the data were submitted to the qualitative analysis in the matrix distance program FITOPAC, the similarity of the isolates could be assessed.


Asunto(s)
Gatos/microbiología , Perros/microbiología , Microsporum/clasificación , Animales , Antifúngicos/farmacología , Carbono/metabolismo , Endopeptidasas/metabolismo , Microsporum/efectos de los fármacos , Microsporum/metabolismo , Nitrógeno/metabolismo , Fenotipo , Fosfolipasas/metabolismo
12.
Med Mycol ; 39(5): 463-8, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-12054058

RESUMEN

Microsporum canis is the most prevalent dermatophyte of domestic animals. Several enzymes produced by dermatophytes, particularly keratinases, are considered to play a role in the virulence of this fungus. To investigate the possible relationship between the clinical status of M. canis infection and enzymatic activity of isolates, we studied the relationship between keratinase, elastase, lipase and DNase levels produced in vitro by different isolates and virulence as expressed in a guinea pig model. Samples isolated from symptomatic dogs and cats showed a statistically significantly (P < 0.05) higher keratinase activity than samples isolated from asymptomatic animals. Experimental infection of guinea pigs showed that a strain with high in vitro keratinase activity induced acute infection, which resolved clinically and mycologically faster than the infection induced by a strain with low keratinase activity. This suggested a strong correlation between high keratinase activity and the development of symptoms. The same correlation was not observed for other enzymes tested.


Asunto(s)
Microsporum/enzimología , Péptido Hidrolasas/metabolismo , Animales , Gatos , Desoxirribonucleasas/metabolismo , Perros , Femenino , Cobayas , Lipasa/metabolismo , Masculino , Microsporum/patogenicidad , Elastasa Pancreática/metabolismo , Virulencia
13.
Eur J Gastroenterol Hepatol ; 12(2): 165-73, 2000 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-10741930

RESUMEN

BACKGROUND: Correa's hypothesis proposes that gastric carcinogenesis is due to atrophic gastritis and hypochlorhydria which permit gastric bacterial colonization, the reduction of dietary nitrates to nitrites and the formation of potentially carcinogenic N-nitroso compounds (NOCs). OBJECTIVE: To test the hypothesis that omeprazole-induced hypochlorhydria is associated with increased intra-gastric concentrations of nitrate-reducing bacteria (NRB), nitrites and NOCs. DESIGN: Single-blind study in healthy volunteers. PARTICIPANTS: Fourteen healthy subjects (seven female, mean age 24 years), free of Helicobacter pylori infection, received a one-week course of placebo followed by a two-week course of omeprazole, 20 mg daily. METHODS: Fasted gastric samples, aspirated using a sterile double-lumen nasogastric tube at the end of the 1 st week (placebo) and the 2nd and 3rd weeks (omeprazole), were cultured aerobically and anaerobically; gastric pH and intra-gastric concentrations of nitrates, nitrites and NOCs were also determined. RESULTS: After weeks 1, 2 and 3, the intra-gastric concentrations of nitrate-reducing bacteria exceeded 10(5) colony-forming units (c.f.u.)/ml in 3, 7 and 9 subjects, respectively (P > 0.05). A gastric pH greater than 4.0 was associated with increased NRB (P < 0.05); however, neither increased gastric pH nor increased NRB, alone or in combination, was associated with increased intra-gastric concentrations of nitrites or NOCs (P > 0.05). CONCLUSIONS: A two-week increase in gastric pH in healthy, H. pylori-negative subjects was associated with increased intra-gastric concentrations of nitrate-reducing bacteria but not of nitrites or N-nitroso compounds. These data suggest that reduced gastric acid secretion is not a necessary precursor to the formation of carcinogenic N-nitroso compounds and that other mechanisms should be invoked to explain gastric carcinogenesis.


Asunto(s)
Aclorhidria/inducido químicamente , Carcinógenos/análisis , Inhibidores Enzimáticos/efectos adversos , Compuestos Nitrosos/análisis , Omeprazol/efectos adversos , Neoplasias Gástricas/etiología , Estómago/microbiología , Adulto , Femenino , Humanos , Concentración de Iones de Hidrógeno , Masculino , Valores de Referencia , Método Simple Ciego , Estómago/química
14.
Neurology ; 49(4): 991-8, 1997 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-9339678

RESUMEN

It is widely agreed that after two or more seizures patients should be given antiepileptic treatment, but there is still controversy about the treatment of patients after a first unprovoked seizure. In a multicenter, randomized, open trial, patients with a first tonic-clonic seizure were randomized to immediate treatment (carbamazepine, phenytoin, phenobarbital, or sodium valproate) or to treatment only after another seizure. Fifty-two (24%) of the 215 patients randomized to immediate treatment and 85 (42%) of the 204 randomized to delayed treatment experienced seizure recurrence during follow-up. Age, acute treatment of the seizure with benzodiazepines, remote etiologic factors, and EEG abnormalities were significant predictors of relapse. Of the immediately treated patients, 87% had no seizures for a year and 68% had no seizures for 2 years, whereas only slightly fewer initially untreated patients (83% and 60%) achieved these endpoints. Patients treated after the first seizure and those treated after seizure relapse had the same time-dependent probability of achieving 1 and 2 seizure-free years. None of the variables that were prognostic predictors of relapse was significantly associated with the probability of having 1 or 2 years of seizure control. Anticonvulsants in patients presenting a first tonic-clonic seizure reduce the risk of relapse; however, 50% of patients who are not treated will never experience a second seizure. Moreover, the probability of long-term remission is not influenced by treatment of the first seizure.


Asunto(s)
Anticonvulsivantes/administración & dosificación , Epilepsia Tónico-Clónica/tratamiento farmacológico , Epilepsia Tónico-Clónica/fisiopatología , Adolescente , Adulto , Anticonvulsivantes/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Inducción de Remisión , Factores de Tiempo
15.
J Child Neurol ; 10(6): 467-71, 1995 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-8576558

RESUMEN

We studied the seizure and polygraphic patterns of 18 patients with Angelman's syndrome. All patients showed movement problems. Eleven patients were also reported to have long-lasting periods of jerky movements. The polygraphic recording showed a myoclonic status epilepticus in nine of them. Seven patients had partial seizures with eye deviation and vomiting, similar to those of childhood occipital epilepsies. These seizures and electroencephalographic patterns suggest that Angelman's syndrome occurs in most of the patients as a nonprogressive, age-dependent myoclonic encephalopathy with a prominent occipital involvement. These findings indicate that, whereas ataxia is a constant symptom in Angelman's syndrome, the occurrence of a transient myoclonic status epilepticus may account for the recurrence of different abnormal movements, namely the jerky ones.


Asunto(s)
Síndrome de Angelman/fisiopatología , Encéfalo/fisiopatología , Epilepsias Parciales/fisiopatología , Estado Epiléptico/fisiopatología , Adolescente , Adulto , Niño , Preescolar , Electroencefalografía , Femenino , Humanos , Lactante , Masculino , Trastornos del Movimiento/fisiopatología
16.
Gut ; 36(4): 539-43, 1995 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-7737560

RESUMEN

To test the hypothesis that Helicobacter pylori infection is associated with a decreased intragastric acidity during omeprazole therapy, ambulatory 24 hour dual point gastric pH recordings were performed in 18 H pylori positive and 14 H pylori negative subjects. There was a four to six week washout period between the two pH recordings made in each subject after one week courses of placebo or omeprazole, 20 mg daily. During placebo, median 24 hour pH values were not different in the corpus (H pylori positive = 1.5, negative = 1.4; p = 0.9) or antrum (H pylori positive = 1.3, negative = 1.2; p = 0.1). However, during omeprazole treatment, median 24 hour pH values were higher in H pylori positive subjects, both in the corpus (H pylori positive = 5.5, negative = 4.0; p = 0.001) and antrum (H pylori positive = 5.5, negative = 3.5; p = 0.0004). During placebo treatment, the only difference between the two groups was a higher later nocturnal pH in the antrum in the H pylori positive group. During omeprazole treatment, gastric pH was higher both in the corpus and in the antrum in the H pylori positive group for all periods, except for mealtime in the corpus. These data indicate that omeprazole produces a greater decrease in gastric acidity in subjects with H pylori infection than in those who are H pylori negative. It is not, however, known whether there is a causal relationship between H pylori infection and increased omeprazole efficacy.


Asunto(s)
Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Omeprazol/uso terapéutico , Adulto , Pruebas Respiratorias , Estudios Cruzados , Método Doble Ciego , Femenino , Determinación de la Acidez Gástrica , Humanos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Masculino , Persona de Mediana Edad , Método Simple Ciego , Factores de Tiempo
17.
Ital J Neurol Sci ; 15(9): 463-71, 1994 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7721549

RESUMEN

We studied 11 infants (7 males) with combined infantile spasms (IS) and partial seizures. The age of onset of the spasms ranged from 6 days to 9 months. All of the children had neurological or CT/MRI abnormalities, and five also had a family history of epilepsy. The clinical and polygraphic patterns of the clusters of spasms combined with partial seizures were analysed. Ten infants were followed-up for a mean period of 3 years, 4 months (range 1 year 10 months to 4 years 11 months). At the last check-up, the seizures were controlled in 2 patients; the others continued to have spasms and/or partial seizures. All of the patients developed mild to severe psychomotor retardation. This condition defines a subgroup of infants presenting with IS, which is distinct from West syndrome.


Asunto(s)
Electroencefalografía , Epilepsias Parciales/fisiopatología , Espasmos Infantiles/fisiopatología , Electromiografía , Epilepsias Parciales/complicaciones , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Contracción Muscular/fisiología , Espasmos Infantiles/complicaciones , Resultado del Tratamiento
18.
Gut ; 35(4): 455-60, 1994 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-8174980

RESUMEN

Previous studies have suggested that profound inhibition of gastric acid secretion may increase exposure to potentially carcinogenic N-nitroso compounds. The aim of this study was to find out if the proton pump inhibitor omeprazole (20 mg daily) is associated with increased concentrations of potentially carcinogenic N-nitroso compounds in gastric juice. The volume of gastric contents, number of bacteria, and concentrations of nitrates, nitrites, and N-nitroso compounds was determined in gastric aspirates obtained after an overnight fast in 14 healthy volunteers (7M:7F) after one week of treatment with placebo, and one and two weeks' treatment with omeprazole. Median bacterial concentrations were 1.0 x 10(4) (range 5.0 x 10(3)-5.0 x 10(6)) colony forming units (CFU)/ml after one weeks' treatment with placebo and increased significantly to 4.0 x 10(5) (0-3.3 x 10(7)) CFU/ml after two weeks' treatment with omeprazole (p < 0.05). A similar increase was seen in the concentration of nitrate reducing bacteria. There was no difference in the volume of gastric aspirates after treatment with omeprazole when compared with placebo (65 (29-155) ml v 42 (19-194) ml). The concentration of N-nitroso compounds was 0.13 (0-1.0) mumol/l after two weeks of omeprazole, which was not significantly different from that seen with placebo (0.15 (0-0.61) mumol/l). There was also no increase in the concentrations of nitrates or nitrites. It is concluded that omeprazole (20 mg once daily) for two weeks in healthy volunteers is associated with gastric bacterial proliferation but does not increase concentrations of N-nitroso compounds.


Asunto(s)
Jugo Gástrico/microbiología , Nitratos/metabolismo , Nitritos/metabolismo , Compuestos Nitrosos/metabolismo , Omeprazol/farmacología , Adulto , Bacterias/efectos de los fármacos , Bacterias/crecimiento & desarrollo , Bacterias/metabolismo , Femenino , Jugo Gástrico/metabolismo , Humanos , Concentración de Iones de Hidrógeno/efectos de los fármacos , Masculino , Persona de Mediana Edad , Método Simple Ciego
20.
Farmaco ; 48(8): 1113-20, 1993 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8216673

RESUMEN

-2',3'-Seco nucleosides 5 carrying fluorine and sulfur substituents at C-3' and C-5', respectively, of acyclic sugar moiety were synthesized in enantiomerically and diastereoisomerically pure form. These products and some structurally similar 1',2'-seco-2'-nor-and 1',2'-seco-nucleosides 3 and 4 were tested in vitro for cytotoxicity and antiviral activity. At non-cytotoxic concentrations the compounds were inactive against human immunodeficiency virus and herpes simplex virus type-1.


Asunto(s)
Antivirales/síntesis química , Nucleósidos/síntesis química , Animales , Antivirales/farmacología , Línea Celular , Supervivencia Celular/efectos de los fármacos , VIH-1/efectos de los fármacos , Herpesvirus Humano 1/efectos de los fármacos , Humanos , Nucleósidos/farmacología , Estereoisomerismo , Células Vero
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA